封面
市場調查報告書
商品編碼
1422660

癲癇治療藥物市場 - 按藥物類別、類型、癲癇類型、給藥途徑、年齡層、配銷通路、全球預測,2024 年 - 2032 年

Epilepsy Treatment Drugs Market - By Drug Class, Type, Seizure Type, Route of Administration, Age Group, Distribution Channel, Global Forecast, 2024 - 2032

出版日期: | 出版商: Global Market Insights Inc. | 英文 220 Pages | 商品交期: 2-3個工作天內

價格

預計從 2024 年到 2032 年,癲癇治療藥物市場規模將以超過 4.6% 的CAGR擴大。神經科學研究和藥物開發的不斷進步,加上對癲癇機制的更深入了解,正在導致新型、更有效的治療方案的推出。

全球癲癇盛行率的上升以及對早期診斷的日益關注正在推動對癲癇治療藥物的需求。例如,2023 年 1 月,Zydus Lifesciences 向美國市場推出了一種學名藥癲癇治療藥物托吡酯緩釋膠囊。個人化醫療和精準治療的推動以及正在進行的臨床試驗正在鼓勵新藥的開發。此外,製藥公司增加投資開發安全性更高、副作用更少的療法也將有助於市場擴張。

癲癇治療藥物市場分為藥物類別、類型、給藥途徑、年齡層、癲癇類型、配銷通路和地區。

由於其既定療效、醫生廣泛熟悉和成本效益,第一代藥物類別的市場價值預計在 2024 年至 2032 年間將以 4.1% 的CAGR成長。儘管新藥物類別取得了進步,但第一代藥物的可靠性和可及性將繼續推動他們對確保癲癇治療策略的重要性不斷提高的需求。

學名藥領域的癲癇治療藥物產業預計將在癲癇治療藥物市場中累積可觀的收入佔有率,到 2032 年複合CAGR為5.1%。這種成長可歸因於品牌藥物的可負擔性、可及性的提高以及專利的到期。學名藥提供了具有同等治療效果、價格實惠的替代品,進一步贏得了醫療保健提供者和患者的青睞。此外,有利的監管框架加上對降低醫療成本的日益關注將促進該領域的成長。

從區域來看,亞太地區癲癇治療藥物市場預計在2024 年至2032 年間將以5% 的成長率擴大。這是由於醫療基礎設施的改善、癲癇盛行率的上升以及政府為解決神經系統疾病而採取的措施蓬勃發展。此外,製藥公司和醫療保健組織之間合作的激增以及治療方案的不斷進步將推動區域產業的擴張。

目錄

第 1 章:方法與範圍

第 2 章:執行摘要

第 3 章:癲癇治療藥物產業見解

  • 產業格局,2018 - 2032
  • 產業影響力
    • 成長動力
      • 癲癇盛行率上升
      • 增加研發活動投資
      • 對癲癇新療法的需求不斷增加
      • 提高認知和早期診斷
    • 產業陷阱與挑戰
      • 與抗癲癇藥物相關的不良反應
      • 專利到期
  • 成長潛力分析
  • 監管環境
  • 管道分析
  • 波特的分析
  • PESTEL分析

第 4 章:競爭格局

  • 介紹
  • 公司矩陣分析
  • 主要市場參與者的競爭分析
  • 競爭定位矩陣
  • 戰略儀表板

第 5 章:癲癇治療藥物市場估計與預測:按藥物類別,2018-2032

  • 主要動向:依藥物類別
  • 第一代
  • 第二代
  • 第三代

第 6 章:癲癇治療藥物市場估計與預測:按類型,2018-2032

  • 主要動向:依類型
  • 品牌化
  • 泛型

第 7 章:癲癇治療藥物市場估計與預測:按給藥途徑,2018-2032 年

  • 主要動向:按給藥途徑
  • 口服
  • 鼻腔
  • 可注射
  • 直腸

第 8 章:癲癇治療藥物市場估計和預測:按年齡層,2018-2032

  • 主要動向:依年齡段
  • 兒科
  • 成人

第 9 章:癲癇治療藥物市場估計與預測:按癲癇類型,2018-2032

  • 主要動向:按發作類型
  • 局部性癲癇發作
  • 全身性癲癇發作
  • 合併癲癇發作

第 10 章:癲癇治療藥物市場估計與預測:按配銷通路,2018-2032

  • 主要動向:按配銷通路
  • 醫院藥房
  • 零售藥局
  • 網路藥局

第 11 章:癲癇治療藥物市場估計與預測:按地區,2018 - 2032

  • 主要動向:按地區
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 歐洲其他地區
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 亞太地區其他地區
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地區
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 中東和非洲其他地區

第 12 章:公司簡介

  • UCB Pharma S.A.
  • GlaxoSmithKline Plc
  • Sanofi
  • SK Biopharmaceuticals
  • Eisai Co., Ltd.
  • Novartis AG
  • Novel Laboratories Inc.
  • Pfizer Inc.
  • Neurelis, Inc.
  • Bausch Health Companies Inc.
  • Dr. Reddy's Laboratories
  • Sumitomo Pharma
  • Jazz Pharmaceuticals, Inc.
  • Sun Pharmaceutical Industries Ltd.
Product Code: 7730

Epilepsy treatment drugs market size is projected to expand at over 4.6% CAGR from 2024 to 2032. The increasing advances in neuroscience research and drug development coupled with the deeper understanding of epilepsy mechanisms is leading to the introduction of novel and more effective treatment options.

The rising global prevalence of epilepsy and the increased focus on early diagnosis is fueling the demand for epilepsy treatment drugs. For instance, in January 2023, Zydus Lifesciences introduced a generic epilepsy treatment medication, Topiramate extended-release capsules, for the U.S. market. The push for personalized medicine and precision treatments, along with ongoing clinical trials is encouraging the development of new drugs. Additionally, the increasing investments by pharmaceutical companies on developing therapies with improved safety profiles and reduced side effects will also assist in the market expansion.

The epilepsy treatment drugs market is categorized into drug class, type, route of administration, age group, seizure type, distribution channel, and region.

The market value from the first-generation drug class segment is estimated to rise at 4.1% CAGR between 2024 and 2032, owing to their established efficacy, widespread physician familiarity, and cost-effectiveness. Despite advancements in newer drug classes, the reliability and accessibility of first-generation drugs will continue to drive their demand for ensuring rising significance in epilepsy treatment strategies.

Epilepsy treatment drugs industry from the generic type segment is projected to accumulate substantial revenue share of the epilepsy treatment drug market, depicting 5.1% CAGR through 2032. The growth can be attributed to the affordability, increased accessibility, and the expiration of patents for branded drugs. Generic medications offer affordable alternatives with equivalent therapeutic efficacy, further garnering preference among healthcare providers and patients. Moreover, the favorable regulatory frameworks coupled with the rising focus on reducing healthcare costs will boost the segment growth.

Regionally, the Asia Pacific epilepsy treatment drug market is projected to expand at 5% growth rate between 2024 and 2032. This is due to the improving healthcare infrastructure, the rising prevalence of epilepsy, and thriving government initiatives to address neurological disorders. Additionally, the surge in collaborations between pharmaceutical companies and healthcare organizations along with the rising advancements in treatment options will drive the regional industry expansion.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market definition
  • 1.2 Base estimates & calculations
  • 1.3 Forecast calculation
  • 1.4 Data validation
  • 1.5 Data sources
    • 1.5.1 Primary
    • 1.5.2 Secondary
      • 1.5.2.1 Paid sources
      • 1.5.2.2 Public sources

Chapter 2 Executive Summary

  • 2.1 Epilepsy treatment drugs industry 360 degree synopsis, 2018 - 2032 (USD Million)
    • 2.1.1 Business trends
    • 2.1.2 Regional trends
    • 2.1.3 Drug class trends
    • 2.1.4 Type trends
    • 2.1.5 Route of administration trends
    • 2.1.6 Age group trends
    • 2.1.7 Seizure type trends
    • 2.1.8 Distribution channel trends

Chapter 3 Epilepsy Treatment Drugs Industry Insights

  • 3.1 Industry landscape, 2018 - 2032 (USD Million)
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Rising prevalence of epilepsy
      • 3.2.1.2 Increasing investments in R&D activities
      • 3.2.1.3 Increasing demand for novel treatment for epilepsy
      • 3.2.1.4 Growing awareness and early diagnosis
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 Adverse effects associated with the antiepileptic drugs
      • 3.2.2.2 Patent expiration
  • 3.3 Growth potential analysis
    • 3.3.1 By drug class
    • 3.3.2 By type
    • 3.3.3 By route of administration
    • 3.3.4 By age group
    • 3.3.5 By seizure type
    • 3.3.6 By distribution channel
  • 3.4 Regulatory landscape
  • 3.5 Pipeline analysis
  • 3.6 Porter's analysis
  • 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company matrix analysis, 2023
  • 4.3 Competitive analysis of major market players, 2023
  • 4.4 Competitive positioning matrix, 2023
  • 4.5 Strategic dashboard, 2023

Chapter 5 Epilepsy Treatment Drugs Market Estimates and Forecast, By Drug Class, 2018-2032 (USD Million)

  • 5.1 Key trends, by drug class
  • 5.2 First-generation
  • 5.3 Second-generation
  • 5.4 Third generation

Chapter 6 Epilepsy Treatment Drugs Market Estimates and Forecast, By Type, 2018-2032 (USD Million)

  • 6.1 Key trends, by type
  • 6.2 Branded
  • 6.3 Generics

Chapter 7 Epilepsy Treatment Drugs Market Estimates and Forecast, By Route of Administration, 2018-2032 (USD Million)

  • 7.1 Key trends, by route of administration
  • 7.2 Oral
  • 7.3 Nasal
  • 7.4 Injectable
  • 7.5 Rectal

Chapter 8 Epilepsy Treatment Drugs Market Estimates and Forecast, By Age Group, 2018-2032 (USD Million)

  • 8.1 Key trends, by age group
  • 8.2 Pediatric
  • 8.3 Adult

Chapter 9 Epilepsy Treatment Drugs Market Estimates and Forecast, By Seizure Type, 2018-2032 (USD Million)

  • 9.1 Key trends, by seizure type
  • 9.2 Focal seizure
  • 9.3 Generalized seizure
  • 9.4 Combined seizure

Chapter 10 Epilepsy Treatment Drugs Market Estimates and Forecast, By Distribution Channel, 2018-2032 (USD Million)

  • 10.1 Key trends, by distribution channel
  • 10.2 Hospital pharmacies
  • 10.3 Retail pharmacies
  • 10.4 Online pharmacies

Chapter 11 Epilepsy Treatment Drugs Market Estimates and Forecast, By Region, 2018 - 2032 (USD Million)

  • 11.1 Key trends, by region
  • 11.2 North America
    • 11.2.1 U.S.
    • 11.2.2 Canada
  • 11.3 Europe
    • 11.3.1 Germany
    • 11.3.2 UK
    • 11.3.3 France
    • 11.3.4 Spain
    • 11.3.5 Italy
    • 11.3.6 Rest of Europe
  • 11.4 Asia Pacific
    • 11.4.1 China
    • 11.4.2 Japan
    • 11.4.3 India
    • 11.4.4 Australia
    • 11.4.5 Rest of Asia Pacific
  • 11.5 Latin America
    • 11.5.1 Brazil
    • 11.5.2 Mexico
    • 11.5.3 Rest of Latin America
  • 11.6 Middle East & Africa
    • 11.6.1 South Africa
    • 11.6.2 Saudi Arabia
    • 11.6.3 Rest of Middle East & Africa

Chapter 12 Company Profiles

  • 12.1 UCB Pharma S.A.
  • 12.2 GlaxoSmithKline Plc
  • 12.3 Sanofi
  • 12.4 SK Biopharmaceuticals
  • 12.5 Eisai Co., Ltd.
  • 12.6 Novartis AG
  • 12.7 Novel Laboratories Inc.
  • 12.8 Pfizer Inc.
  • 12.9 Neurelis, Inc.
  • 12.10 Bausch Health Companies Inc.
  • 12.11 Dr. Reddy's Laboratories
  • 12.12 Sumitomo Pharma
  • 12.13 Jazz Pharmaceuticals, Inc.
  • 12.14 Sun Pharmaceutical Industries Ltd.

Data Tables

  • TABLE 1 Market revenue, by drug class (2023)
  • TABLE 2 Market revenue, by type (2023)
  • TABLE 3 Market revenue, by route of administration (2023)
  • TABLE 4 Market revenue, by age group (2023)
  • TABLE 5 Market revenue, by seizure type (2023)
  • TABLE 6 Market revenue, by distribution channel (2023)
  • TABLE 7 Market share, by region (2023)
  • TABLE 8 Global epilepsy treatment drugs market size, by region, 2018 - 2023 (USD Million)
  • TABLE 9 Global epilepsy treatment drugs market size, by region, 2024 - 2032 (USD Million)
  • TABLE 10 Global epilepsy treatment drugs market size, by drug class, 2018 - 2023 (USD Million)
  • TABLE 11 Global epilepsy treatment drugs market size, by drug class, 2024 - 2032 (USD Million)
  • TABLE 12 Global epilepsy treatment drugs market size, by type, 2018 - 2023 (USD Million)
  • TABLE 13 Global epilepsy treatment drugs market size, by type, 2024 - 2032 (USD Million)
  • TABLE 14 Global epilepsy treatment drugs market size, by route of administration, 2018 - 2023 (USD Million)
  • TABLE 15 Global epilepsy treatment drugs market size, by route of administration, 2024 - 2032 (USD Million)
  • TABLE 16 Global epilepsy treatment drugs market size, by age group, 2018 - 2023 (USD Million)
  • TABLE 17 Global epilepsy treatment drugs market size, by age group, 2024 - 2032 (USD Million)
  • TABLE 18 Global epilepsy treatment drugs market size, by seizure type, 2018 - 2023 (USD Million)
  • TABLE 19 Global epilepsy treatment drugs market size, by seizure type, 2024 - 2032 (USD Million)
  • TABLE 20 Global epilepsy treatment drugs market size, by distribution channel, 2018 - 2023 (USD Million)
  • TABLE 21 Global epilepsy treatment drugs market size, by distribution channel, 2024 - 2032 (USD Million)
  • TABLE 22 Industry impact forces
  • TABLE 23 First-generation market, 2018 - 2023 (USD Million)
  • TABLE 24 First -generation market, 2024 - 2032 (USD Million)
  • TABLE 25 Second-generation market, 2018 - 2023 (USD Million)
  • TABLE 26 Second -generation market, 2024 - 2032 (USD Million)
  • TABLE 27 Third-generation market, 2018 - 2023 (USD Million)
  • TABLE 28 Third-generation market, 2024 - 2032 (USD Million)
  • TABLE 29 Branded market, 2018 - 2023 (USD Million)
  • TABLE 30 Branded market, 2024 - 2032 (USD Million)
  • TABLE 31 Generics market, 2018 - 2023 (USD Million)
  • TABLE 32 Generics market, 2024 - 2032 (USD Million)
  • TABLE 33 Oral market, 2018 - 2023 (USD Million)
  • TABLE 34 Oral market, 2024 - 2032 (USD Million)
  • TABLE 35 Nasal market, 2018 - 2023 (USD Million)
  • TABLE 36 Nasal market, 2024 - 2032 (USD Million)
  • TABLE 37 Injectable market, 2018 - 2023 (USD Million)
  • TABLE 38 Injectable market, 2024 - 2032 (USD Million)
  • TABLE 39 Rectal market, 2018 - 2023 (USD Million)
  • TABLE 40 Rectal market, 2024 - 2032 (USD Million)
  • TABLE 41 Pediatric market, 2018 - 2023 (USD Million)
  • TABLE 42 Pediatric market, 2024 - 2032 (USD Million)
  • TABLE 43 Adult market, 2018 - 2023 (USD Million)
  • TABLE 44 Adult market, 2024 - 2032 (USD Million)
  • TABLE 45 Focal seizure market, 2018 - 2023 (USD Million)
  • TABLE 46 Focal seizure market, 2018 - 2023 (USD Million)
  • TABLE 47 Generalized seizure market, 2018 - 2023 (USD Million)
  • TABLE 48 Generalized seizure market, 2024 - 2032 (USD Million)
  • TABLE 49 Combined seizure market, 2018 - 2023 (USD Million)
  • TABLE 50 Combined seizure market, 2024 - 2032 (USD Million)
  • TABLE 51 Hospital pharmacies market, 2018 - 2023 (USD Million)
  • TABLE 52 Hospital pharmacies market, 2024 - 2032 (USD Million)
  • TABLE 53 Retail pharmacies market, 2018 - 2023 (USD Million)
  • TABLE 54 Retail pharmacies market, 2024 - 2032 (USD Million)
  • TABLE 55 Online pharmacies market, 2018 - 2023 (USD Million)
  • TABLE 56 Online pharmacies market, 2024 - 2032 (USD Million)
  • TABLE 57 North America epilepsy treatment drugs market size, by country, 2018 - 2023 (USD Million)
  • TABLE 58 North America epilepsy treatment drugs market size, by country, 2024 - 2032 (USD Million)
  • TABLE 59 North America epilepsy treatment drugs market size, by drug class, 2018 - 2023 (USD Million)
  • TABLE 60 North America epilepsy treatment drugs market size, by drug class, 2024 - 2032 (USD Million)
  • TABLE 61 North America epilepsy treatment drugs market size, by type, 2018 - 2023 (USD Million)
  • TABLE 62 North America epilepsy treatment drugs market size, by type, 2024 - 2032 (USD Million)
  • TABLE 63 North America epilepsy treatment drugs market size, by route of administration, 2018 - 2023 (USD Million)
  • TABLE 64 North America epilepsy treatment drugs market size, by route of administration, 2024 - 2032 (USD Million)
  • TABLE 65 North America epilepsy treatment drugs market size, by age group, 2018 - 2023 (USD Million)
  • TABLE 66 North America epilepsy treatment drugs market size, by age group, 2024 - 2032 (USD Million)
  • TABLE 67 North America epilepsy treatment drugs market size, by seizure type, 2018 - 2023 (USD Million)
  • TABLE 68 North America epilepsy treatment drugs market size, by seizure type, 2024 - 2032 (USD Million)
  • TABLE 69 North America epilepsy treatment drugs market size, by distribution channel, 2018 - 2023 (USD Million)
  • TABLE 70 North America epilepsy treatment drugs market size, by distribution channel, 2024 - 2032 (USD Million)
  • TABLE 71 U.S. epilepsy treatment drugs market size, by drug class, 2018 - 2023 (USD Million)
  • TABLE 72 U.S. epilepsy treatment drugs market size, by drug class, 2024 - 2032 (USD Million)
  • TABLE 73 U.S. epilepsy treatment drugs market size, by type, 2018 - 2023 (USD Million)
  • TABLE 74 U.S. epilepsy treatment drugs market size, by type, 2024 - 2032 (USD Million)
  • TABLE 75 U.S. epilepsy treatment drugs market size, by route of administration, 2018 - 2023 (USD Million)
  • TABLE 76 U.S. epilepsy treatment drugs market size, by route of administration, 2024 - 2032 (USD Million)
  • TABLE 77 U.S. epilepsy treatment drugs market size, by age group, 2018 - 2023 (USD Million)
  • TABLE 78 U.S. epilepsy treatment drugs market size, by age group, 2024 - 2032 (USD Million)
  • TABLE 79 U.S. epilepsy treatment drugs market size, by seizure type, 2018 - 2023 (USD Million)
  • TABLE 80 U.S. epilepsy treatment drugs market size, by seizure type, 2024 - 2032 (USD Million)
  • TABLE 81 U.S. epilepsy treatment drugs market size, by distribution channel, 2018 - 2023 (USD Million)
  • TABLE 82 U.S. epilepsy treatment drugs market size, by distribution channel, 2024 - 2032 (USD Million)
  • TABLE 83 Canada epilepsy treatment drugs market size, by drug class, 2018 - 2023 (USD Million)
  • TABLE 84 Canada epilepsy treatment drugs market size, by drug class, 2024 - 2032 (USD Million)
  • TABLE 85 Canada epilepsy treatment drugs market size, by type, 2018 - 2023 (USD Million)
  • TABLE 86 Canada epilepsy treatment drugs market size, by type, 2024 - 2032 (USD Million)
  • TABLE 87 Canada epilepsy treatment drugs market size, by route of administration, 2018 - 2023 (USD Million)
  • TABLE 88 Canada epilepsy treatment drugs market size, by route of administration, 2024 - 2032 (USD Million)
  • TABLE 89 Canada epilepsy treatment drugs market size, by age group, 2018 - 2023 (USD Million)
  • TABLE 90 Canada epilepsy treatment drugs market size, by age group, 2024 - 2032 (USD Million)
  • TABLE 91 Canada epilepsy treatment drugs market size, by seizure type, 2018 - 2023 (USD Million)
  • TABLE 92 Canada epilepsy treatment drugs market size, by seizure type, 2024 - 2032 (USD Million)
  • TABLE 93 Canada epilepsy treatment drugs market size, by distribution channel, 2018 - 2023 (USD Million)
  • TABLE 94 Canada epilepsy treatment drugs market size, by distribution channel, 2024 - 2032 (USD Million)
  • TABLE 95 Europe epilepsy treatment drugs market size, by country, 2018 - 2023 (USD Million)
  • TABLE 96 Europe epilepsy treatment drugs market size, by country, 2024 - 2032 (USD Million)
  • TABLE 97 Europe epilepsy treatment drugs market size, by drug class, 2018 - 2023 (USD Million)
  • TABLE 98 Europe epilepsy treatment drugs market size, by drug class, 2024 - 2032 (USD Million)
  • TABLE 99 Europe epilepsy treatment drugs market size, by type, 2018 - 2023 (USD Million)
  • TABLE 100 Europe epilepsy treatment drugs market size, by type, 2024 - 2032 (USD Million)
  • TABLE 101 Europe epilepsy treatment drugs market size, by route of administration, 2018 - 2023 (USD Million)
  • TABLE 102 Europe epilepsy treatment drugs market size, by route of administration, 2024 - 2032 (USD Million)
  • TABLE 103 Europe epilepsy treatment drugs market size, by age group, 2018 - 2023 (USD Million)
  • TABLE 104 Europe epilepsy treatment drugs market size, by age group, 2024 - 2032 (USD Million)
  • TABLE 105 Europe epilepsy treatment drugs market size, by seizure type, 2018 - 2023 (USD Million)
  • TABLE 106 Europe epilepsy treatment drugs market size, by seizure type, 2024 - 2032 (USD Million)
  • TABLE 107 Europe epilepsy treatment drugs market size, by distribution channel, 2018 - 2023 (USD Million)
  • TABLE 108 Europe epilepsy treatment drugs market size, by distribution channel, 2024 - 2032 (USD Million)
  • TABLE 109 Germany epilepsy treatment drugs market size, by drug class, 2018 - 2023 (USD Million)
  • TABLE 110 Germany epilepsy treatment drugs market size, by drug class, 2024 - 2032 (USD Million)
  • TABLE 111 Germany epilepsy treatment drugs market size, by type, 2018 - 2023 (USD Million)
  • TABLE 112 Germany epilepsy treatment drugs market size, by type, 2024 - 2032 (USD Million)
  • TABLE 113 Germany epilepsy treatment drugs market size, by route of administration, 2018 - 2023 (USD Million)
  • TABLE 114 Germany epilepsy treatment drugs market size, by route of administration, 2024 - 2032 (USD Million)
  • TABLE 115 Germany epilepsy treatment drugs market size, by age group, 2018 - 2023 (USD Million)
  • TABLE 116 Germany epilepsy treatment drugs market size, by age group, 2024 - 2032 (USD Million)
  • TABLE 117 Germany epilepsy treatment drugs market size, by seizure type, 2018 - 2023 (USD Million)
  • TABLE 118 Germany epilepsy treatment drugs market size, by seizure type, 2024 - 2032 (USD Million)
  • TABLE 119 Germany epilepsy treatment drugs market size, by distribution channel, 2018 - 2023 (USD Million)
  • TABLE 120 Germany epilepsy treatment drugs market size, by distribution channel, 2024 - 2032 (USD Million)
  • TABLE 121 UK epilepsy treatment drugs market size, by drug class, 2018 - 2023 (USD Million)
  • TABLE 122 UK epilepsy treatment drugs market size, by drug class, 2024 - 2032 (USD Million)
  • TABLE 123 UK epilepsy treatment drugs market size, by type, 2018 - 2023 (USD Million)
  • TABLE 124 UK epilepsy treatment drugs market size, by type, 2024 - 2032 (USD Million)
  • TABLE 125 UK epilepsy treatment drugs market size, by route of administration, 2018 - 2023 (USD Million)
  • TABLE 126 UK epilepsy treatment drugs market size, by route of administration, 2024 - 2032 (USD Million)
  • TABLE 127 UK epilepsy treatment drugs market size, by age group, 2018 - 2023 (USD Million)
  • TABLE 128 UK epilepsy treatment drugs market size, by age group, 2024 - 2032 (USD Million)
  • TABLE 129 UK epilepsy treatment drugs market size, by seizure type, 2018 - 2023 (USD Million)
  • TABLE 130 UK epilepsy treatment drugs market size, by seizure type, 2024 - 2032 (USD Million)
  • TABLE 131 UK epilepsy treatment drugs market size, by distribution channel, 2018 - 2023 (USD Million)
  • TABLE 132 UK epilepsy treatment drugs market size, by distribution channel, 2024 - 2032 (USD Million)
  • TABLE 133 France epilepsy treatment drugs market size, by drug class, 2018 - 2023 (USD Million)
  • TABLE 134 France epilepsy treatment drugs market size, by drug class, 2024 - 2032 (USD Million)
  • TABLE 135 France epilepsy treatment drugs market size, by type, 2018 - 2023 (USD Million)
  • TABLE 136 France epilepsy treatment drugs market size, by type, 2024 - 2032 (USD Million)
  • TABLE 137 France epilepsy treatment drugs market size, by route of administration, 2018 - 2023 (USD Million)
  • TABLE 138 France epilepsy treatment drugs market size, by route of administration, 2024 - 2032 (USD Million)
  • TABLE 139 France epilepsy treatment drugs market size, by age group, 2018 - 2023 (USD Million)
  • TABLE 140 France epilepsy treatment drugs market size, by age group, 2024 - 2032 (USD Million)
  • TABLE 141 France epilepsy treatment drugs market size, by seizure type, 2018 - 2023 (USD Million)
  • TABLE 142 France epilepsy treatment drugs market size, by seizure type, 2024 - 2032 (USD Million)
  • TABLE 143 France epilepsy treatment drugs market size, by distribution channel, 2018 - 2023 (USD Million)
  • TABLE 144 France epilepsy treatment drugs market size, by distribution channel, 2024 - 2032 (USD Million)
  • TABLE 145 Spain epilepsy treatment drugs market size, by drug class, 2018 - 2023 (USD Million)
  • TABLE 146 Spain epilepsy treatment drugs market size, by drug class, 2024 - 2032 (USD Million)
  • TABLE 147 Spain epilepsy treatment drugs market size, by type, 2018 - 2023 (USD Million)
  • TABLE 148 Spain epilepsy treatment drugs market size, by type, 2024 - 2032 (USD Million)
  • TABLE 149 Spain epilepsy treatment drugs market size, by route of administration, 2018 - 2023 (USD Million)
  • TABLE 150 Spain epilepsy treatment drugs market size, by route of administration, 2024 - 2032 (USD Million
  • TABLE 151 Spain epilepsy treatment drugs market size, by age group, 2018 - 2023 (USD Million)
  • TABLE 152 Spain epilepsy treatment drugs market size, by age group, 2024 - 2032 (USD Million)
  • TABLE 153 Spain epilepsy treatment drugs market size, by seizure type, 2018 - 2023 (USD Million)
  • TABLE 154 Spain epilepsy treatment drugs market size, by seizure type, 2024 - 2032 (USD Million)
  • TABLE 155 Spain epilepsy treatment drugs market size, by distribution channel, 2018 - 2023 (USD Million)
  • TABLE 156 Spain epilepsy treatment drugs market size, by distribution channel, 2024 - 2032 (USD Million)
  • TABLE 157 Italy epilepsy treatment drugs market size, by drug class, 2018 - 2023 (USD Million)
  • TABLE 158 Italy epilepsy treatment drugs market size, by drug class, 2024 - 2032 (USD Million)
  • TABLE 159 Italy epilepsy treatment drugs market size, by type, 2018 - 2023 (USD Million)
  • TABLE 160 Italy epilepsy treatment drugs market size, by type, 2024 - 2032 (USD Million)
  • TABLE 161 Italy epilepsy treatment drugs market size, by route of administration, 2018 - 2023 (USD Million)
  • TABLE 162 Italy epilepsy treatment drugs market size, by route of administration, 2024 - 2032 (USD Million)
  • TABLE 163 Italy epilepsy treatment drugs market size, by age group, 2018 - 2023 (USD Million)
  • TABLE 164 Italy epilepsy treatment drugs market size, by age group, 2024 - 2032 (USD Million)
  • TABLE 165 Italy epilepsy treatment drugs market size, by seizure type, 2018 - 2023 (USD Million)
  • TABLE 166 Italy epilepsy treatment drugs market size, by seizure type, 2024 - 2032 (USD Million)
  • TABLE 167 Italy epilepsy treatment drugs market size, by distribution channel, 2018 - 2023 (USD Million)
  • TABLE 168 Italy epilepsy treatment drugs market size, by distribution channel, 2024 - 2032 (USD Million)
  • TABLE 169 Rest of Europe epilepsy treatment drugs market size, by drug class, 2018 - 2023 (USD Million)
  • TABLE 170 Rest of Europe epilepsy treatment drugs market size, by drug class, 2024 - 2032 (USD Million)
  • TABLE 171 Rest of Europe epilepsy treatment drugs market size, by type, 2018 - 2023 (USD Million)
  • TABLE 172 Rest of Europe epilepsy treatment drugs market size, by type, 2024 - 2032 (USD Million)
  • TABLE 173 Rest of Europe epilepsy treatment drugs market size, by route of administration, 2018 - 2023 (USD Million)
  • TABLE 174 Rest of Europe epilepsy treatment drugs market size, by route of administration, 2024 - 2032 (USD Million)
  • TABLE 175 Rest of Europe epilepsy treatment drugs market size, by age group, 2018 - 2023 (USD Million)
  • TABLE 176 Rest of Europe epilepsy treatment drugs market size, by age group, 2024 - 2032 (USD Million)
  • TABLE 177 Rest of Europe epilepsy treatment drugs market size, by seizure type, 2018 - 2023 (USD Million)
  • TABLE 178 Rest of Europe epilepsy treatment drugs market size, by seizure type, 2024 - 2032 (USD Million)
  • TABLE 179 Rest of Europe epilepsy treatment drugs market size, by distribution channel, 2018 - 2023 (USD Million)
  • TABLE 180 Rest of Europe epilepsy treatment drugs market size, by distribution channel, 2024 - 2032 (USD Million)
  • TABLE 181 Asia Pacific epilepsy treatment drugs market size, by country, 2018 - 2023 (USD Million)
  • TABLE 182 Asia Pacific epilepsy treatment drugs market size, by country, 2024 - 2032 (USD Million)
  • TABLE 183 Asia Pacific epilepsy treatment drugs market size, by drug class, 2018 - 2023 (USD Million)
  • TABLE 184 Asia Pacific epilepsy treatment drugs market size, by drug class, 2024 - 2032 (USD Million)
  • TABLE 185 Asia Pacific epilepsy treatment drugs market size, by type, 2018 - 2023 (USD Million)
  • TABLE 186 Asia Pacific epilepsy treatment drugs market size, by type, 2024 - 2032 (USD Million)
  • TABLE 187 Asia Pacific epilepsy treatment drugs market size, by route of administration, 2018 - 2023 (USD Million)
  • TABLE 188 Asia Pacific epilepsy treatment drugs market size, by route of administration, 2024 - 2032 (USD Million)
  • TABLE 189 Asia Pacific epilepsy treatment drugs market size, by age group, 2018 - 2023 (USD Million)
  • TABLE 190 Asia Pacific epilepsy treatment drugs market size, by age group, 2024 - 2032 (USD Million)
  • TABLE 191 Asia Pacific epilepsy treatment drugs market size, by seizure type, 2018 - 2023 (USD Million)
  • TABLE 192 Asia Pacific epilepsy treatment drugs market size, by seizure type, 2024 - 2032 (USD Million)
  • TABLE 193 Asia Pacific epilepsy treatment drugs market size, by distribution channel, 2018 - 2023 (USD Million)
  • TABLE 194 Asia Pacific epilepsy treatment drugs market size, by distribution channel, 2024 - 2032 (USD Million)
  • TABLE 195 China epilepsy treatment drugs market size, by drug class, 2018 - 2023 (USD Million)
  • TABLE 196 China epilepsy treatment drugs market size, by drug class, 2024 - 2032 (USD Million)
  • TABLE 197 China epilepsy treatment drugs market size, by type, 2018 - 2023 (USD Million)
  • TABLE 198 China epilepsy treatment drugs market size, by type, 2024 - 2032 (USD Million)
  • TABLE 199 China epilepsy treatment drugs market size, by route of administration, 2018 - 2023 (USD Million)
  • TABLE 200 China epilepsy treatment drugs market size, by route of administration, 2024 - 2032 (USD Million)
  • TABLE 201 China epilepsy treatment drugs market size, by age group, 2018 - 2023 (USD Million)
  • TABLE 202 China epilepsy treatment drugs market size, by age group, 2024 - 2032 (USD Million)
  • TABLE 203 China epilepsy treatment drugs market size, by seizure type, 2018 - 2023 (USD Million)
  • TABLE 204 China epilepsy treatment drugs market size, by seizure type, 2024 - 2032 (USD Million)
  • TABLE 205 China epilepsy treatment drugs market size, by distribution channel, 2018 - 2023 (USD Million)
  • TABLE 206 China epilepsy treatment drugs market size, by distribution channel, 2024 - 2032 (USD Million)
  • TABLE 207 Japan epilepsy treatment drugs market size, by drug class, 2018 - 2023 (USD Million)
  • TABLE 208 Japan epilepsy treatment drugs market size, by drug class, 2024 - 2032 (USD Million)
  • TABLE 209 Japan epilepsy treatment drugs market size, by type, 2018 - 2023 (USD Million)
  • TABLE 210 Japan epilepsy treatment drugs market size, by type, 2024 - 2032 (USD Million)
  • TABLE 211 Japan epilepsy treatment drugs market size, by route of administration, 2018 - 2023 (USD Million)
  • TABLE 212 Japan epilepsy treatment drugs market size, by route of administration, 2024 - 2032 (USD Million)
  • TABLE 213 Japan epilepsy treatment drugs market size, by age group, 2018 - 2023 (USD Million)
  • TABLE 214 Japan epilepsy treatment drugs market size, by age group, 2024 - 2032 (USD Million)
  • TABLE 215 Japan epilepsy treatment drugs market size, by seizure type, 2018 - 2023 (USD Million)
  • TABLE 216 Japan epilepsy treatment drugs market size, by seizure type, 2024 - 2032 (USD Million)
  • TABLE 217 Japan epilepsy treatment drugs market size, by distribution channel, 2018 - 2023 (USD Million)
  • TABLE 218 Japan epilepsy treatment drugs market size, by distribution channel, 2024 - 2032 (USD Million)
  • TABLE 219 India epilepsy treatment drugs market size, by drug class, 2018 - 2023 (USD Million)
  • TABLE 220 India epilepsy treatment drugs market size, by drug class, 2024 - 2032 (USD Million)
  • TABLE 221 India epilepsy treatment drugs market size, by type, 2018 - 2023 (USD Million)
  • TABLE 222 India epilepsy treatment drugs market size, by type, 2024 - 2032 (USD Million)
  • TABLE 223 India epilepsy treatment drugs market size, by route of administration, 2018 - 2023 (USD Million)
  • TABLE 224 India epilepsy treatment drugs market size, by route of administration, 2024 - 2032 (USD Million)
  • TABLE 225 India epilepsy treatment drugs market size, by age group, 2018 - 2023 (USD Million)
  • TABLE 226 India epilepsy treatment drugs market size, by age group, 2024 - 2032 (USD Million)
  • TABLE 227 India epilepsy treatment drugs market size, by seizure type, 2018 - 2023 (USD Million)
  • TABLE 228 India epilepsy treatment drugs market size, by seizure type, 2024 - 2032 (USD Million)
  • TABLE 229 India epilepsy treatment drugs market size, by distribution channel, 2018 - 2023 (USD Million)
  • TABLE 230 India epilepsy treatment drugs market size, by distribution channel, 2024 - 2032 (USD Million)
  • TABLE 231 Australia epilepsy treatment drugs market size, by drug class, 2018 - 2023 (USD Million)
  • TABLE 232 Australia epilepsy treatment drugs market size, by drug class, 2024 - 2032 (USD Million)
  • TABLE 233 Australia epilepsy treatment drugs market size, by type, 2018 - 2023 (USD Million)
  • TABLE 234 Australia epilepsy treatment drugs market size, by type, 2024 - 2032 (USD Million)
  • TABLE 235 Australia epilepsy treatment drugs market size, by route of administration, 2018 - 2023 (USD Million)
  • TABLE 236 Australia epilepsy treatment drugs market size, by route of administration, 2024 - 2032 (USD Million)
  • TABLE 237 Australia epilepsy treatment drugs market size, by age group, 2018 - 2023 (USD Million)
  • TABLE 238 Australia epilepsy treatment drugs market size, by age group, 2024 - 2032 (USD Million)
  • TABLE 239 Australia epilepsy treatment drugs market size, by seizure type, 2018 - 2023 (USD Million)
  • TABLE 240 Australia epilepsy treatment drugs market size, by seizure type, 2024 - 2032 (USD Million)
  • TABLE 241 Australia epilepsy treatment drugs market size, by distribution channel, 2018 - 2023 (USD Million)
  • TABLE 242 Australia epilepsy treatment drugs market size, by distribution channel, 2024 - 2032 (USD Million)
  • TABLE 243 Rest of Asia Pacific epilepsy treatment drugs market size, by drug class, 2018 - 2023 (USD Million)
  • TABLE 244 Rest of Asia Pacific epilepsy treatment drugs market size, by drug class, 2024 - 2032 (USD Million)
  • TABLE 245 Rest of Asia Pacific epilepsy treatment drugs market size, by type, 2018 - 2023 (USD Million)
  • TABLE 246 Rest of Asia Pacific epilepsy treatment drugs market size, by type, 2024 - 2032 (USD Million)
  • TABLE 247 Rest of Asia Pacific epilepsy treatment drugs market size, by route of administration, 2018 - 2023 (USD Million)
  • TABLE 248 Rest of Asia Pacific epilepsy treatment drugs market size, by route of administration, 2024 - 2032 (USD Million)
  • TABLE 249 Rest of Asia Pacific epilepsy treatment drugs market size, by age group, 2018 - 2023 (USD Million)
  • TABLE 250 Rest of Asia Pacific epilepsy treatment drugs market size, by age group, 2024 - 2032 (USD Million)
  • TABLE 251 Rest of Asia Pacific epilepsy treatment drugs market size, by seizure type, 2018 - 2023 (USD Million)
  • TABLE 252 Rest of Asia Pacific epilepsy treatment drugs market size, by seizure type, 2024 - 2032 (USD Million)
  • TABLE 253 Rest of Asia Pacific epilepsy treatment drugs market size, by distribution channel, 2018 - 2023 (USD Million)
  • TABLE 254 Rest of Asia Pacific epilepsy treatment drugs market size, by distribution channel, 2024 - 2032 (USD Million)
  • TABLE 255 Latin America epilepsy treatment drugs market size, by country, 2018 - 2023 (USD Million)
  • TABLE 256 Latin America epilepsy treatment drugs market size, by country, 2024 - 2032 (USD Million)
  • TABLE 257 Latin America epilepsy treatment drugs market size, by drug class, 2018 - 2023 (USD Million)
  • TABLE 258 Latin America epilepsy treatment drugs market size, by drug class, 2024 - 2032 (USD Million)
  • TABLE 259 Latin America epilepsy treatment drugs market size, by type, 2018 - 2023 (USD Million)
  • TABLE 260 Latin America epilepsy treatment drugs market size, by type, 2024 - 2032 (USD Million)
  • TABLE 261 Latin America epilepsy treatment drugs market size, by route of administration, 2018 - 2023 (USD Million)
  • TABLE 262 Latin America epilepsy treatment drugs market size, by route of administration, 2024 - 2032 (USD Million)
  • TABLE 263 Latin America epilepsy treatment drugs market size, by age group, 2018 - 2023 (USD Million)
  • TABLE 264 Latin America epilepsy treatment drugs market size, by age group, 2024 - 2032 (USD Million)
  • TABLE 265 Latin America epilepsy treatment drugs market size, by seizure type, 2018 - 2023 (USD Million)
  • TABLE 266 Latin America epilepsy treatment drugs market size, by seizure type, 2024 - 2032 (USD Million)
  • TABLE 267 Latin America epilepsy treatment drugs market size, by distribution channel, 2018 - 2023 (USD Million)
  • TABLE 268 Latin America epilepsy treatment drugs market size, by distribution channel, 2024 - 2032 (USD Million)
  • TABLE 269 Brazil epilepsy treatment drugs market size, by drug class, 2018 - 2023 (USD Million)
  • TABLE 270 Brazil epilepsy treatment drugs market size, by drug class, 2024 - 2032 (USD Million)
  • TABLE 271 Brazil epilepsy treatment drugs market size, by type, 2018 - 2023 (USD Million)
  • TABLE 272 Brazil epilepsy treatment drugs market size, by type, 2024 - 2032 (USD Million)
  • TABLE 273 Brazil epilepsy treatment drugs market size, by route of administration, 2018 - 2023 (USD Million)
  • TABLE 274 Brazil epilepsy treatment drugs market size, by route of administration, 2024 - 2032 (USD Million)
  • TABLE 275 Brazil epilepsy treatment drugs market size, by age group, 2018 - 2023 (USD Million)
  • TABLE 276 Brazil epilepsy treatment drugs market size, by age group, 2024 - 2032 (USD Million)
  • TABLE 277 Brazil epilepsy treatment drugs market size, by seizure type, 2018 - 2023 (USD Million)
  • TABLE 278 Brazil epilepsy treatment drugs market size, by seizure type, 2024 - 2032 (USD Million)
  • TABLE 279 Brazil epilepsy treatment drugs market size, by distribution channel, 2018 - 2023 (USD Million)
  • TABLE 280 Brazil epilepsy treatment drugs market size, by distribution channel, 2024 - 2032 (USD Million)
  • TABLE 281 Mexico epilepsy treatment drugs market size, by drug class, 2018 - 2023 (USD Million)
  • TABLE 282 Mexico epilepsy treatment drugs market size, by drug class, 2024 - 2032 (USD Million)
  • TABLE 283 Mexico epilepsy treatment drugs market size, by type, 2018 - 2023 (USD Million)
  • TABLE 284 Mexico epilepsy treatment drugs market size, by type, 2024 - 2032 (USD Million)
  • TABLE 285 Mexico epilepsy treatment drugs market size, by route of administration, 2018 - 2023 (USD Million)
  • TABLE 286 Mexico epilepsy treatment drugs market size, by route of administration, 2024 - 2032 (USD Million)
  • TABLE 287 Mexico epilepsy treatment drugs market size, by age group, 2018 - 2023 (USD Million)
  • TABLE 288 Mexico epilepsy treatment drugs market size, by age group, 2024 - 2032 (USD Million)
  • TABLE 289 Mexico epilepsy treatment drugs market size, by seizure type, 2018 - 2023 (USD Million)
  • TABLE 290 Mexico epilepsy treatment drugs market size, by seizure type, 2024 - 2032 (USD Million)
  • TABLE 291 Mexico epilepsy treatment drugs market size, by distribution channel, 2018 - 2023 (USD Million)
  • TABLE 292 Mexico epilepsy treatment drugs market size, by distribution channel, 2024 - 2032 (USD Million)
  • TABLE 293 Rest of Latin America epilepsy treatment drugs market size, by drug class, 2018 - 2023 (USD Million)
  • TABLE 294 Rest of Latin America epilepsy treatment drugs market size, by drug class, 2024 - 2032 (USD Million)
  • TABLE 295 Rest of Latin America epilepsy treatment drugs market size, by type, 2018 - 2023 (USD Million)
  • TABLE 296 Rest of Latin America epilepsy treatment drugs market size, by type, 2024 - 2032 (USD Million)
  • TABLE 297 Rest of Latin America epilepsy treatment drugs market size, by route of administration, 2018 - 2023 (USD Million)
  • TABLE 298 Rest of Latin America epilepsy treatment drugs market size, by route of administration, 2024 - 2032 (USD Million)
  • TABLE 299 Rest of Latin America epilepsy treatment drugs market size, by age group, 2018 - 2023 (USD Million)
  • TABLE 300 Rest of Latin America epilepsy treatment drugs market size, by age group, 2024 - 2032 (USD Million)
  • TABLE 301 Rest of Latin America epilepsy treatment drugs market size, by seizure type, 2018 - 2023 (USD Million)
  • TABLE 302 Rest of Latin America epilepsy treatment drugs market size, by seizure type, 2024 - 2032 (USD Million)
  • TABLE 303 Rest of Latin America epilepsy treatment drugs market size, by distribution channel, 2018 - 2023 (USD Million)
  • TABLE 304 Rest of Latin America epilepsy treatment drugs market size, by distribution channel, 2024 - 2032 (USD Million)
  • TABLE 305 Middle East & Africa epilepsy treatment drugs market size, by country, 2018 - 2023 (USD Million)
  • TABLE 306 Middle East & Africa epilepsy treatment drugs market size, by country, 2024 - 2032 (USD Million)
  • TABLE 307 Middle East & Africa epilepsy treatment drugs market size, by drug class, 2018 - 2023 (USD Million)
  • TABLE 308 Middle East & Africa epilepsy treatment drugs market size, by drug class, 2024 - 2032 (USD Million)
  • TABLE 309 Middle East & Africa epilepsy treatment drugs market size, by type, 2018 - 2023 (USD Million)
  • TABLE 310 Middle East & Africa epilepsy treatment drugs market size, by type, 2024 - 2032 (USD Million)
  • TABLE 311 Middle East & Africa epilepsy treatment drugs market size, by route of administration, 2018 - 2023 (USD Million)
  • TABLE 312 Middle East & Africa epilepsy treatment drugs market size, by route of administration, 2024 - 2032 (USD Million)
  • TABLE 313 Middle East & Africa epilepsy treatment drugs market size, by age group, 2018 - 2023 (USD Million)
  • TABLE 314 Middle East & Africa epilepsy treatment drugs market size, by age group, 2024 - 2032 (USD Million)
  • TABLE 315 Middle East & Africa epilepsy treatment drugs market size, by seizure type, 2018 - 2023 (USD Million)
  • TABLE 316 Middle East & Africa epilepsy treatment drugs market size, by seizure type, 2024 - 2032 (USD Million)
  • TABLE 317 Middle East & Africa epilepsy treatment drugs market size, by distribution channel, 2018 - 2023 (USD Million)
  • TABLE 318 Middle East & Africa epilepsy treatment drugs market size, by distribution channel, 2024 - 2032 (USD Million)
  • TABLE 319 South Africa epilepsy treatment drugs market size, by drug class, 2018 - 2023 (USD Million)
  • TABLE 320 South Africa epilepsy treatment drugs market size, by drug class, 2024 - 2032 (USD Million)
  • TABLE 321 South Africa epilepsy treatment drugs market size, by type, 2018 - 2023 (USD Million)
  • TABLE 322 South Africa epilepsy treatment drugs market size, by type, 2024 - 2032 (USD Million)
  • TABLE 323 South Africa epilepsy treatment drugs market size, by route of administration, 2018 - 2023 (USD Million)
  • TABLE 324 South Africa epilepsy treatment drugs market size, by route of administration, 2024 - 2032 (USD Million)
  • TABLE 325 South Africa epilepsy treatment drugs market size, by age group, 2018 - 2023 (USD Million)
  • TABLE 326 South Africa epilepsy treatment drugs market size, by age group, 2024 - 2032 (USD Million)
  • TABLE 327 South Africa epilepsy treatment drugs market size, by seizure type, 2018 - 2023 (USD Million)
  • TABLE 328 South Africa epilepsy treatment drugs market size, by seizure type, 2024 - 2032 (USD Million)
  • TABLE 329 South Africa epilepsy treatment drugs market size, by distribution channel, 2018 - 2023 (USD Million)
  • TABLE 330 South Africa epilepsy treatment drugs market size, by distribution channel, 2024 - 2032 (USD Million)
  • TABLE 331 Saudi Arabia epilepsy treatment drugs market size, by drug class, 2018 - 2023 (USD Million)
  • TABLE 332 Saudi Arabia epilepsy treatment drugs market size, by drug class, 2024 - 2032 (USD Million)
  • TABLE 333 Saudi Arabia epilepsy treatment drugs market size, by type, 2018 - 2023 (USD Million)
  • TABLE 334 Saudi Arabia epilepsy treatment drugs market size, by type, 2024 - 2032 (USD Million)
  • TABLE 335 Saudi Arabia epilepsy treatment drugs market size, by route of administration, 2018 - 2023 (USD Million)
  • TABLE 336 Saudi Arabia epilepsy treatment drugs market size, by route of administration, 2024 - 2032 (USD Million
  • TABLE 337 Saudi Arabia epilepsy treatment drugs market size, by age group, 2018 - 2023 (USD Million)
  • TABLE 338 Saudi Arabia epilepsy treatment drugs market size, by age group, 2024 - 2032 (USD Million)
  • TABLE 339 Saudi Arabia epilepsy treatment drugs market size, by seizure type, 2018 - 2023 (USD Million)
  • TABLE 340 Saudi Arabia epilepsy treatment drugs market size, by seizure type, 2024 - 2032 (USD Million)
  • TABLE 341 Saudi Arabia epilepsy treatment drugs market size, by distribution channel, 2018 - 2023 (USD Million)
  • TABLE 342 Saudi Arabia epilepsy treatment drugs market size, by distribution channel, 2024 - 2032 (USD Million)
  • TABLE 343 Rest of Middle East & Africa epilepsy treatment drugs market size, by drug class, 2018 - 2023 (USD Million)
  • TABLE 344 Rest of Middle East & Africa epilepsy treatment drugs market size, by drug class, 2024 - 2032 (USD Million)
  • TABLE 345 Rest of Middle East & Africa epilepsy treatment drugs market size, by type, 2018 - 2023 (USD Million)
  • TABLE 346 Rest of Middle East & Africa epilepsy treatment drugs market size, by type, 2024 - 2032 (USD Million)
  • TABLE 347 Rest of Middle East & Africa epilepsy treatment drugs market size, by route of administration, 2024 - 2032 (USD Million)
  • TABLE 348 Rest of Middle East & Africa epilepsy treatment drugs market size, by route of administration, 2018 - 2023 (USD Million)
  • TABLE 349 Rest of Middle East & Africa epilepsy treatment drugs market size, by age group, 2018 - 2023 (USD Million)
  • TABLE 350 Rest of Middle East & Africa epilepsy treatment drugs market size, by age group, 2024 - 2032 (USD Million)
  • TABLE 351 Rest of Middle East & Africa epilepsy treatment drugs market size, by seizure type, 2018 - 2023 (USD Million)
  • TABLE 352 Rest of Middle East & Africa epilepsy treatment drugs market size, by seizure type, 2024 - 2032 (USD Million)
  • TABLE 353 Rest of Middle East & Africa epilepsy treatment drugs market size, by distribution channel, 2018 - 2023 (USD Million)
  • TABLE 354 Rest of Middle East & Africa epilepsy treatment drugs market size, by distribution channel, 2024 - 2032 (USD Million)

Charts & Figures

  • FIG 1 GMI report coverage: critical research elements
  • FIG 2 Top-down approach
  • FIG 3 Market estimation and forecast methodology
  • FIG 4 Market forecasting methodology
  • FIG 5 Breakdown of primary participants
  • FIG 6 Epilepsy treatment drugs industry 360 degree synopsis, 2018 - 2032
  • FIG 7 Industry landscape analysis, 2018 - 2032 (USD Million)
  • FIG 8 Growth potential analysis, by drug class
  • FIG 9 Growth potential analysis, by type
  • FIG 10 Growth potential analysis, by route of administration
  • FIG 11 Growth potential analysis, by age group
  • FIG 12 Growth potential analysis, by seizure type
  • FIG 13 Growth potential analysis, by distribution channel
  • FIG 14 Porter's analysis
  • FIG 15 PESTEL analysis
  • FIG 16 Company matrix analysis, 2023
  • FIG 17 Competitive analysis of major market players, 2023
  • FIG 18 Competitive positioning matrix, 2023
  • FIG 19 Strategic dashboard, 2023